286 related articles for article (PubMed ID: 21435360)
1. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules.
Lee WR; Shen SC; Al-Suwayeh SA; Yang HH; Yuan CY; Fang JY
J Control Release; 2011 Aug; 153(3):240-8. PubMed ID: 21435360
[TBL] [Abstract][Full Text] [Related]
2. Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk.
Lee WR; Shen SC; Aljuffali IA; Lin YK; Huang CW; Fang JY
Eur J Pharm Sci; 2016 Sep; 92():1-10. PubMed ID: 27345564
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of macromolecules by erbium:YAG laser.
Fang JY; Lee WR; Shen SC; Wang HY; Fang CL; Hu CH
J Control Release; 2004 Nov; 100(1):75-85. PubMed ID: 15491812
[TBL] [Abstract][Full Text] [Related]
4. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser.
Lee WR; Shen SC; Pai MH; Yang HH; Yuan CY; Fang JY
J Control Release; 2010 Jul; 145(2):124-33. PubMed ID: 20359510
[TBL] [Abstract][Full Text] [Related]
5. Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.
Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
J Pharm Sci; 2014 Nov; 103(11):3542-3552. PubMed ID: 25187109
[TBL] [Abstract][Full Text] [Related]
6. Skin permeation of small-molecule drugs, macromolecules, and nanoparticles mediated by a fractional carbon dioxide laser: the role of hair follicles.
Lee WR; Shen SC; Al-Suwayeh SA; Yang HH; Li YC; Fang JY
Pharm Res; 2013 Mar; 30(3):792-802. PubMed ID: 23138262
[TBL] [Abstract][Full Text] [Related]
7. Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.
Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
Pharm Res; 2014 Feb; 31(2):382-93. PubMed ID: 24022680
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin.
Lee WR; Shen SC; Zhuo RZ; Wang KC; Fang JY
Hum Gene Ther; 2009 Jun; 20(6):580-8. PubMed ID: 19239381
[TBL] [Abstract][Full Text] [Related]
9. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
Bachhav YG; Heinrich A; Kalia YN
Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
[TBL] [Abstract][Full Text] [Related]
10. Post-irradiation recovery time strongly influences fractional laser-facilitated skin absorption.
Lee WR; Hsiao CY; Huang TH; Wang CL; Alalaiwe A; Chen EL; Fang JY
Int J Pharm; 2019 Jun; 564():48-58. PubMed ID: 30999045
[TBL] [Abstract][Full Text] [Related]
11. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination.
Lee WR; Pan TL; Wang PW; Zhuo RZ; Huang CM; Fang JY
J Control Release; 2008 Jun; 128(3):200-8. PubMed ID: 18471920
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous drug delivery by liposomes using fractional laser technology.
Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: erbium:YAG laser versus CO₂ laser.
Lee WR; Shen SC; Chen WY; Aljuffali IA; Suen SY; Fang JY
Eur J Pharm Biopharm; 2014 Apr; 86(3):315-23. PubMed ID: 23962771
[TBL] [Abstract][Full Text] [Related]
14. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN
J Control Release; 2010 Aug; 146(1):31-6. PubMed ID: 20678988
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation.
Lee WR; Shen SC; Fang CL; Zhuo RZ; Fang JY
Lasers Surg Med; 2008 Sep; 40(7):468-76. PubMed ID: 18727021
[TBL] [Abstract][Full Text] [Related]
16. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.
Lee WR; Shen SC; Sung CT; Liu PY; Fang JY
Pharm Res; 2018 Apr; 35(7):128. PubMed ID: 29700662
[TBL] [Abstract][Full Text] [Related]
17. Erbium:YAG laser resurfacing increases skin permeability and the risk of excessive absorption of antibiotics and sunscreens: the influence of skin recovery on drug absorption.
Lee WR; Shen SC; Al-Suwayeh SA; Li YC; Fang JY
Toxicol Lett; 2012 Jun; 211(2):150-8. PubMed ID: 22483991
[TBL] [Abstract][Full Text] [Related]
18. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies.
Yu J; Kalaria DR; Kalia YN
J Control Release; 2011 Nov; 156(1):53-9. PubMed ID: 21803083
[TBL] [Abstract][Full Text] [Related]
19. Fractional laser-assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate.
Taudorf EH; Lerche CM; Erlendsson AM; Philipsen PA; Hansen SH; Janfelt C; Paasch U; Anderson RR; Haedersdal M
Lasers Surg Med; 2016 Jul; 48(5):519-29. PubMed ID: 26846733
[TBL] [Abstract][Full Text] [Related]
20. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
